A 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivative For Pharmaceutical Use, And The Use Of A 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivate With Substantially Undefined Crystal Shape For Preparing Said 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivative

Patent No. EP2470529 (titled "A 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivative For Pharmaceutical Use, And The Use Of A 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivate With Substantially Undefined Crystal Shape For Preparing Said 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivative") was filed by Medichem S.A. on Jul 23, 2010. The application was issued on Nov 19, 2014.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2470529

MEDICHEM S.A.
Application Number
EP10737869A
Filing Date
Jul 23, 2010
Status
Opposition Rejected
Mar 6, 2020
Publication Date
Nov 19, 2014